FIELD: chemistry.
SUBSTANCE: invention relates to a novel derivative of ferrocene 1-(1,1,1,3,3,3-hexafluoro-2-ferrocenylprop-2-yl)-imidazole of formula
which shows an antitumour activity. Also claimed is a method of its obtaining (versions).
EFFECT: invention makes it possible to obtain the novel derivative of ferrocene, which can be applied in medicine for chemotherapy of oncologic diseases.
4 cl, 1 dwg, 2 tbl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF PRODUCING FERROCENYLALKYL DERIVATIVES OF C,C'-DIPYRAZOLYLSELENIDE | 2019 |
|
RU2732409C1 |
FERROCENYLALKYL DERIVATIVES OF DIPYRAZOLYLSELENIDES AS BIOLOGICALLY ACTIVE COMPOUNDS AND METHODS FOR PRODUCTION THEREOF (VERSIONS) | 2019 |
|
RU2714891C1 |
AGENT SHOWING ANTITUMOR AND ANALGETIC ACTIVITY | 1996 |
|
RU2121839C1 |
AGENTS SUPPRESSING PROLIFERATION OF CANCER CELLS | 1993 |
|
RU2098096C1 |
DERIVATIVE OF THE CLASS OF N-GLYCOSIDES INDOLO[2,3-A]PYRROLO[3,4-C]CARBAZOLE-5,7-DIONE - N-{12-(β-D-XYLOPYRANOSYL)-5,7-DIOXO-INDOLO[2,3-A]PYRROLO[3,4-C]CARBAZOL-6-YL} PYRIDINE-2-CARBOXAMIDE, WHICH HAS CYTOTOXIC AND ANTITUMOR ACTIVITY | 2017 |
|
RU2667906C1 |
COMPLEX IRON COMPOUNDS SUCH AS FERROCENYLALKYL POLYFLUROAZOLES HAVING ANTITUMOR ACTIVITY | 1996 |
|
RU2089507C1 |
AGENT SHOWING ANTITUMOR ACTIVITY | 1991 |
|
RU2025125C1 |
MEDICATION INCREASING ANTITUMOUR EFFECT OF METHOTREXATE | 2009 |
|
RU2411947C1 |
MEDIUM WITH ANTI-TUMOUR EFFECT AND METHOD OF ITS OBTAINMENT | 2007 |
|
RU2349317C1 |
1-(4-AMYLHYDROXY-3-NITROBENZYL)-2-METHYL-4-NITRO-5-[BIS-(2- CHLOROETHYL)-AMINOETHYL]-THIOIMIDAZOLE HYDROCHLORIDE SHOWING ANTITUMOR ACTIVITY | 1985 |
|
SU1314627A1 |
Authors
Dates
2014-11-20—Published
2013-07-05—Filed